CEO of Doudna spinout: Within five years, genome editors will have a 'really big impact' on patients' lives
Endpoints News
|
August 12, 2022
X min read
Endpoints News
|
August 12, 2022
Share on Social
More like this
News
Scribe Therapeutics Presents Data on its Epigenetic Long-Term X-Repressor Technology at the 2025 Keystone Symposia on Precision Genome Engineering Conference
March 7, 2025
Read Now
Press
Scribe Therapeutics Presents Data on its Epigenetic Long-Term X-Repressor Technology at the 2025 Keystone Symposia on Precision Genome Engineering Conference
March 7, 2025
Read Now
